| Name | hemoglobin (protein family or complex) |
|---|---|
| Synonyms | Hemoglobin; Hemoglobins |
| Name | methyl bromide |
|---|---|
| CAS | bromomethane |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 3230058 | Iwasaki K: Individual differences in the formation of hemoglobin adducts following exposure to methyl bromide. Ind Health. 1988;26(4):257-62. |
6(0,0,1,1) | Details |
| 12415426 | Muller M, Bunger J, Voss M, Westphal G, Ruhnau P, Hallier E: Phenotyping of human glutathione S-transferase hGSTT1-1: a comparison of two ex vivo routine procedures. Arch Toxicol. 2002 Nov;76(11):634-42. Epub 2002 Aug 9. We have developed a routine ex vivo photometric phenotyping procedure based on the determination of release rates from the hGSTT1-1-catalyzed conjugation of the substrate methyl bromide in EDTA blood samples under standard conditions (1,000 ppm methyl bromide, 10 min incubation). The release rates were standardized to the hemoglobin (Hb) value. |
1(0,0,0,1) | Details |
| 9006104 | Ferranti P, Sannolo N, Mamone G, Fiume I, Carbone V, Tornqvist M, Bergman A, Malorni A: Structural characterization by mass spectrometry of hemoglobin adducts formed after in vivo exposure to methyl bromide. Carcinogenesis. 1996 Dec;17(12):2661-71. residues, the main reactive sites, were fully methylated in hemoglobin exposed to a 10-fold excess of methyl bromide, differently from other residues, including histidines, showing a heterogeneous pattern of methylation that was largely directed by their environment. |
82(0,2,5,7) | Details |
| 3182305 | Iwasaki K: Determination of in mouse hemoglobin following exposure to methyl bromide. Ind Health. 1988;26(3):187-90. |
6(0,0,1,1) | Details |
| 9853387 | Mamone G, Malorni A, Scaloni A, Sannolo N, Basile A, Pocsfalvi G, Ferranti P: Structural analysis and quantitative evaluation of the modifications produced in human hemoglobin by methyl bromide using mass spectrometry and Edman degradation. Rapid Commun Mass Spectrom. 1998;12(22):1783-92. The present study reports a procedure developed for the identification and quantitative analysis of the adducts formed by interaction of methyl bromide with human hemoglobin, based on combined analysis by electrospray mass spectrometry and automated Edman degradation of either intact globin chains or tryptic peptides of globin chains. |
194(2,3,3,4) | Details |
| 7035924 | Djalali-Behzad G, Hussain S, Osterman-Golkar S, Segerback D: Estimation of genetic risks of alkylating agents. Mutat Res. 1981 Nov;84(1):1-9. To study the possibilities of using hemoglobin alkylation for an estimation of DNA alkylation in vivo, mice were treated with 14C-labeled methyl bromide. |
12(0,0,2,2) | Details |
| 2613562 | Iwasaki K, Ito I, Kagawa J: Biological exposure monitoring of methyl bromide workers by determination of hemoglobin adducts. Ind Health. 1989;27(4):181-3. |
6(0,0,1,1) | Details |